Healthcare Global Enterprises Limited

rs,

Mumbai - 400051, Maharashtra, India BSE Limited, Compliance Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001, Maharashtra, India Dear Sir/Madam, Subject : Investor Presenta

INR 51.4 Crore

ment ❖ Revenue from operations of HCG NCHRI LLP for the financial year ended March 31, 2023, was INR 51.4 Crores ABOUT THE TRANSACTION ❖ The company entered into Share Purchase agreement with shareholders of N

100%

iation oncology • First & #1 Comprehensive Cancer Center in private space in Indore • To acquire 100% of hospital on a slump sale basis Strategic Rationale • New Market Entry: Entering a key non-metr

20%

ritable hospital present for Oncology • Attractive market: Oncology market estimated to grow at 15-20% CAGR • Capacity Expansion: Capacity expansion by 100 beds at a nearby location, estimated to be

25%

centration Outcome • #1 player in market • Strong multi-modal clinical practice • Built a CoE • 25%+ EBITDA margin • #1 player in market • Comprehensive cancer care • Deployed latest technology fa

3x

trengthened radiation and medical oncology clinical talent • Diversified doctor revenue mix • 3x capacity addition (1) HMS (multispecialty) was acquired in 2007 but the comprehensive cancer care

16%

E V E N U E R E V E N U E - H C G C e n t e r s ( 1 ) R E V E N U E - M i l a n n C e n t e r s +16% 4,869 4,200 +16% 4,693 4,035 +7% 165 177 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 E

7%

t e r s ( 1 ) R E V E N U E - M i l a n n C e n t e r s +16% 4,869 4,200 +16% 4,693 4,035 +7% 165 177 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 E B I T D A ^ # ( E x c l . I n d o r e

14%

F I T A F T E R T A X ( P r e - I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +14% 760 864 18.1% 17.8% - 34 bps +63% 171 +84% 136 105 74 Q2FY23 Q2FY24 Q2FY23 Q2FY24

18.1%

R T A X ( P r e - I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +14% 760 864 18.1% 17.8% - 34 bps +63% 171 +84% 136 105 74 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q

17.8%

( P r e - I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +14% 760 864 18.1% 17.8% - 34 bps +63% 171 +84% 136 105 74 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23

34 bps

- I N D A S ) P R O F I T A F T E R T A X ( P o s t - I N D A S ) +14% 760 864 18.1% 17.8% - 34 bps +63% 171 +84% 136 105 74 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 Q2FY23 Q2FY24 ^E

“Although the Company believes that such forward‐looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met.”

“No Particulars Capex incurred till 30 th September 2023 Expected Capex for FY24 Total Planned Capex Expected date of Operations 1 2 Ahmedabad – Phase II Whitefield (Extension of Bangalore - COE) 240 34 568 126 852 250 Q1 FY25 Q3 FY25 1.”

Subject

1

Reference

1

Trade Payables

1

Reference

Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) We wish to inform you that the Board of Directors of the Company, at their meeting held on November 09, 2023, inter alia, has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2023 (“Financial Results”). In this respect, we enclose herewith the Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 2023. Request you to take this on record. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a. HealthCare Global Enterprises Limited HCG Tower, # 8, P Kalinga Rao Road, Sampangi Rama Nagar, Bangalore - 560027. 080 33669999 | info@hcgoncology.com | www.hcgoncology.com | CIN : L15200KA1998PLC023489 HEALTHCARE GLOBAL ENTERPRISES LIMITED I NV ESTOR P RESENTATI ON

Trade Payables

Total Outstanding Dues Of Micro Enterprises And Small Enterprises Total Outstanding Dues Of Creditors Other Than Micro Enterprises And Small Enterprises Other Financial Liabilities Other Current Liabilities Provisions Income Tax Liabilities (Net) Total Current Liabilities Total Equity And Liabilities Sep-23 1,393 7,185 8,578 27 8,605 3,966 4,661 18 148 333 85 9,210 684 491 40 2,757 1,460 729 189 24 6,374 24,189 Mar-23 1,391 7,214 8,605 89 8,694 3,628 4,531 0 132 359 124 8,774 365 488 50 2,435 1,404 755 171 25 5,693 23,160 Balance Sheet - Assets (Rs. Mn.) Non-Current Assets Property, Plant And Equipment Capital Work in Progress Rights-of-use Assets Goodwill Other Intangible Assets Intangible Assets Under Development Financial Assets Investments Loans Receivable Other Financial Assets Deferred Tax Assets (Net) Income Tax Assets (Net) Other Non-Current Assets Total Non-Current Assets Current Assets Inventories Financial Assets Trade Receivables Cash And Cash Equivalents Bank Balances Othe